Asia Pacific Dietary Supplements Market

The APAC dietary supplements market is expected to grow from US$ 91,191.59 million in 2021 to US$ 1,40,493.28 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028.

The vegan population in has reported a constant increase over the past few years. Preventing the exploitation of animals and the environment is why consumers have begun to prefer veganism, increasing the demand for plant-based dietary supplements in the market. The market for plant protein components is rapidly expanding as consumers are shifting away from animal proteins. This is likely to change customers’ preferences toward plant-based herbal supplements and botanicals, offering even more potential for the growth of herbal supplements in the dietary supplements sector. Further, consumer preferences are shifting toward botanical extracts due to their increasing desire for clean-label products, rising concerns about sustainability, and an urgent need to avoid allergens. The demographic for these herbal supplements is transitioning from vegans to flexitarians, indicating changes in customer inclinations. Highly concerned about animal cruelty and environmental sustainability, consumers are encouraged to switch to plant-based diets. The changing consumer perception that plant-based products are safer and healthier than animal-derived products is driving the demand for plant-based dietary supplements. The growing trend of veganism is driving manufacturers to launch new products. The preference for plant-based herbal supplements is giving rise to several key trends that are expected to influence the growth of the APAC dietary supplements market in the coming years.

In case of COVID-19, APAC is highly affected specially India. The COVID-19 pandemic is anticipated to cause a significant economic loss in APAC. The emergence of new COVID-19 waves in India and other Asian economies has prolonged the effect of pandemics upon GDP. The ongoing COVID-19 pandemic is anticipated to cause huge disruptions in the growth of various industries of APAC. However, the dietary supplements market is expected to witness an increase in the dietary supplements market as these supplements are beneficial in boosting the immune system. In addition, investment by existing players along with penetration of new players to tap the prevailing opportunities as well as cater to soaring demand for natural, healthy, clean-label products in post-pandemic times.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC dietary supplements market. The APAC dietary supplements market is expected to grow at a good CAGR during the forecast period. 

APAC Dietary Supplements Market Revenue and Forecast to 2028 (US$ Million)    

APAC Dietary Supplements Market Segmentation           

APAC Dietary Supplements Market – By Type

• Vitamins
• Minerals
• Proteins and Amino Acids
• Probiotics
• Blends
• Others

APAC Dietary Supplements Market – By Form

• Tablets
• Capsules and Softgels
• Powders
• Others

APAC Dietary Supplements Market – By Distribution Channel

• Supermarkets and Hypermarkets
• Specialty Stores
• Online Retail
• Others

APAC Dietary Supplements Market, by Country

• China
• Japan
• India
• South Korea    
• Australia
• Rest of APAC

APAC Dietary Supplements Market - Companies Mentioned

• Abbott
• Amway Corp.
• Bayer AG
• Bionova
• GlaxoSmithKline plc. 
• Otsuka Holdings Co., Ltd
• Pfizer Inc. 
• The Bountiful Company

Asia Pacific Dietary Supplements Market Strategic Insights

Asia Pacific Dietary Supplements Market Segmentation Analysis

Asia Pacific Dietary Supplements Market Report Highlights

Asia Pacific Dietary Supplements Report Scope

Asia Pacific Dietary Supplements Market Country and Regional Insights